RNS Number : 1082K Renalytix PLC 31 August 2021 Renalytix plc (" Renalytix " or the " Company ") Renalytix Appoints Daniel J. Levangie to its Board of Directors Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation
RNS Number : 8163J Renalytix PLC 26 August 2021 Renalytix plc (" Renalytix " or the " Company ") Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX TM Testing at Primary Care Level Peer reviewed publication in Journal of Medical Economics supports payer coverage for
RNS Number : 6311I Renalytix PLC 13 August 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 13 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000
RNS Number : 9108H Renalytix PLC 06 August 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 6 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000
RNS Number : 2696H Renalytix PLC 02 August 2021 Renalytix plc (" Renalytix " or the " Company ") Total voting rights New York , 2 August 2021 - Renalytix (LSE: RENX) announces that t he Company's total issued share capital consists of 72,229,786 shares of 0.25 pence each, with each
RNS Number : 1332H Renalytix PLC 30 July 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 30 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O . James Sterling , the Company's Chief Financial Officer, of 12,000
RNS Number : 6767G Renalytix PLC 28 July 2021 Renalytix Appoints Ann Berman to its Board of Directors Berman serves on the board of Lowes Corporation , is a member of the board of trustees of Beth Israel Deaconess , and is a former chief financial officer of Harvard University NEW YORK
RNS Number : 3061G Renalytix PLC 23 July 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 23 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000
RNS Number : 0685G Renalytix PLC 22 July 2021 Renalytix plc (" Renalytix " or the " Company ") Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory Hutson To Build-on Renalytix Quality and Regulatory Strategy for KidneyIntelX Global Commercialization NEW YORK
RNS Number : 7167F Renalytix PLC 19 July 2021 Renalytix plc (" Renalytix " or the " Company ") Exercise of Options and TVR NEW YORK , 19 July, 2021 - Renalytix plc (AIM: RENX) announces that it has issued and allotted 5,000 ordinary shares of 0.25 pence each in the share capital of the